Tracey Lodie, Ph.D., is BlueRock’s senior vice president of translational immunology. Dr. Lodie is a cellular immunologist with over 15 years of drug discovery experience in the areas of autoimmunity, cell therapy, transplant biology, and immuno-oncology. As a seasoned scientist with extensive experience advancing diverse development programs to the clinic, Dr. Lodie is a motivated leader working to advance BlueRock’s therapeutic applications for patients in need. Prior to joining BlueRock, Dr. Lodie served as the vice president of immunology at Syros Pharmaceuticals. Under her leadership, the company developed new research strategies across the areas of autoimmunity and immuno-oncology, and assembled a first-class scientific team to grow the company’s therapeutic expertise. Prior to joining Syros, Dr. Lodie spent most of her career at Genzyme Corp, serving in various roles, including, most recently, as its senior scientific director, head of immune mediated diseases. In addition to her recognition with various awards and honors, Dr. Lodie has experience as an academic instructor, has served in various industry related and non-profit leadership roles, including scientific advisory boards. Dr. Lodie obtained a Ph.D. in immunology and pathology from Boston University School of Medicine and a B.S. in biology from Fairfield University.